We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – Products

Product News

Marina Biotech Describes Integrated Technology Platform for the Development of RNAi-, microRNA- and Antisense-based Therapeutics

Collaboration and licensing partners fund efforts in local and systemic administration of Company's novel delivery systems.
Product News

Speeding Drug Development for Customers - Molecular Profiles Installs Xcelodose System

Molecular Profiles announces the continued expansion of its manufacturing capabilities with the recent purchase of the Xcelodose 120S system. The purchase of this system reflects the company's broader mission to expand the breadth and flexibility of its service offerings.
Product News

Molecular Profiles Installs Xcelodose® System, Speeding Drug Development for Customers

The purchase of the unique system reflects the company’s broader mission to expand the breadth and flexibility of its service offerings.
Product News

New Possibilities for Patients With Difficult to Treat Cancers

First UK Novalis Tx™ radiosurgery launched for treating cancer patients offers the possibility to perform precise painless treatment to tumours in a single patient visit.
Product News

SymBio Launches TREAKISYM® in Japan

Eisai assembles a team of oncology-focused liaisons to oversee each major market area in Japan along with 1,400 medical reps to promote and detail the oncology drug.
Product News

Homogeneous Fluorescence-based Assay for Detecting Intracellular Calcium Mobilisation

Amsbio's Screen Quest™ Calcium Assay kit provides a homogeneous fluorescence-based assay for detecting intracellular calcium mobilisation across a broad spectrum of biological targets.
Product News

Clarient Launches New Breast Cancer Test

The Clarient Insight® Dx breast cancer profile assists physicians in identifying recurrence risk and the need for chemotherapy.
App Note / Case Study

Evaluation of PARP Inhibitors: Performed on BMG LABTECH’s FLUOstar Omega

Poly (ADP-ribose) polymerases (PARP) transfer ADP-ribose to itself and other nuclear proteins such as histones, therefore PARP play a crucial role in regulating DNA repair. A luminescent cellular PARP assay and a fluorescent cell viability assay were performed on BMG LABTECH’s FLUOstar Omega to evaluate PARP inhibitors. PARP inhibition has been demonstrated to potentiate the cytotoxicity of anti-cancer drugs and ionising radiation. The ability of the FLUOstar Omega to measure absorbance, lumines
Product News

Cell Biosciences Introduces Kits for Oncoprotein Analysis

The new kits are optimized for characterization of proteins in the MEK and ERK families on the Firefly™ 3000 Protein Analysis System.
Product News

Affymetrix Announces New Product for Standardising Drug Metabolism Studies

The DMET™ Plus Premier Pack features a comprehensive panel of known pharmacogenetic drug metabolism markers.
Advertisement